2018
DOI: 10.1007/s00259-018-4023-2
|View full text |Cite
|
Sign up to set email alerts
|

The impact of a Bayesian penalized-likelihood reconstruction algorithm on delayed-time-point Ga-68-PSMA PET for improved recurrent prostate cancer detection

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
4
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 6 publications
(4 citation statements)
references
References 5 publications
0
4
0
Order By: Relevance
“…BPL reconstruction (also known as Q.Clear in GE Healthcare Imaging) is a relatively newer reconstruction method with the capacity to improve contrast over OSEM, by applying a noise penalty to individual voxels during reconstruction [ 8 10 ]. From a clinical point-of-view, BPL reconstruction improves the signal-to-noise ratio (SNR) and have been reported to be useful for better localization of the tumour as reported in case reports [ 12 , 15 ]. However, wider adoption of the method showed it cannot increase the sensitivity and specificity of PSMA PET/CT reporting [ 13 ], unable to overcome the day-to-day repeatability of the PSMA PET/CT-derived parameters [ 8 ] and may even exceeds the EARL-accredited maximum values in phantom studies which may impact development of the PSMA-based response criteria [ 16 ].…”
Section: Discussionmentioning
confidence: 99%
“…BPL reconstruction (also known as Q.Clear in GE Healthcare Imaging) is a relatively newer reconstruction method with the capacity to improve contrast over OSEM, by applying a noise penalty to individual voxels during reconstruction [ 8 10 ]. From a clinical point-of-view, BPL reconstruction improves the signal-to-noise ratio (SNR) and have been reported to be useful for better localization of the tumour as reported in case reports [ 12 , 15 ]. However, wider adoption of the method showed it cannot increase the sensitivity and specificity of PSMA PET/CT reporting [ 13 ], unable to overcome the day-to-day repeatability of the PSMA PET/CT-derived parameters [ 8 ] and may even exceeds the EARL-accredited maximum values in phantom studies which may impact development of the PSMA-based response criteria [ 16 ].…”
Section: Discussionmentioning
confidence: 99%
“…Using BPL reconstruction in clinical studies enables improved lesion detection, and this has been shown in a wide variety of studies, for example, for 18 F-FDG in lung nodules [17,19], mediastinal nodes [20] and liver metastases [21]. PET imaging with other tracers also benefits from BPL reconstruction [17], for example, 68 Ga-PSMA [22,23], 68 Ga-DOTATOC [24], 68 Ga-RM2 [25], 90 Y-SIRT [26,27], 18 F-PSMA [28], 18 F-NaF [29], 68 Ga-citrate [30], 18 F-FACBC [31], 13 N-NH3 [32], 11 C-acetate [24] and 89 Zr-immuno-PET [33]. In addition, and perhaps most importantly, BPL is particularly advantageous in patients with high BMI [34,35], because they usually have the greatest background image noise where both the detection and quantification of small abnormalities are most problematic.…”
Section: The Use Of Bayesian Penalized Likelihood (Bpl) Reconstructionmentioning
confidence: 99%
“…[8] Clinically, BPL reconstruction reduces noise, especially in larger patients and within smaller lesions. [9][10][11][12][13][14][15] The maximum standard uptake value (SUVmax) body weight (BW, SUVmax) is a semi-quantitative metric for intensity of radiotracer activity within a region of interest accounting for amount of injected dose and BW while correcting for radioactive time decay [SUVmax 6 Medicine lesions) and this difference tends to be more pronounced in tumors relative to normal liver. [14][15][16][17][18][19][20][21] Alterations in relative SUVmax values, and the relationship between lesion SUV compared to liver, raise concern around accuracy and consistency from interpreting physicians, including when imaging lymphoma.…”
Section: Introductionmentioning
confidence: 99%
“…[8] Clinically, BPL reconstruction reduces noise, especially in larger patients and within smaller lesions. [9–15]…”
Section: Introductionmentioning
confidence: 99%